Inventor
Jerome Wojcik
Inventor
Divonne-les-Bains, FR
Overview
Patents· 3 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes14%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
C07KPeptides14%
C12NMicroorganisms or enzymes14%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms14%
G01NInvestigating or analysing materials by determining their chemical or physical properties14%
A01KAnimal husbandry7%
C12YEnzymes7%
PatentTitleYear
10,703,798Methods of cancer therapy by inhibiting fusion polypeptides comprising fibroblast growth factor receptor 2 (FGFR2) and vinculin (VCL)20209,175,347'Genomic markers for prediction of long-term response to growth hormone (GH) therapy'20156,977,144'Sid nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof'2005Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2005Patents assigned to HYBRIGENICS SA (1)· patent assignee history
2005Based in Paris, FR· patent location history
2015Patents assigned to CROTEAU PASCAL (1)· patent assignee history
2015Patents assigned to DESTENAVES BENOÎT (1)· patent assignee history
2015Patents assigned to MERCK SERONO SA (1)· patent assignee history
2015–2020Based in Divonne-les-Bains, FR· patent location history
2020Patents assigned to DEBIOPHARM INT SA (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CROTEAU PASCAL | 1 | 2015 |
| DEBIOPHARM INT SA | 1 | 2020 |
| DESTENAVES BENOÎT | 1 | 2015 |
| HYBRIGENICS SA | 1 | 2005 |
| MERCK SERONO SA | 1 | 2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Divonne-les-Bains, FR | 2 | 2015–2020 |
| Paris, FR | 1 | 2005 |